Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN) Social Stream



Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN): $32.77

0.22 (-0.67%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add BHVN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#316 of 348

in industry

BIOHAVEN LTD (BHVN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BHVN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 11 $165 $109 $148.6 $45.46 226.88%
2022-01-04 10 $177 $109 $150 $45.46 229.96%
2022-01-07 10 $177 $109 $150.8 $45.46 231.72%
2022-02-03 10 $177 $109 $152.2 $45.46 234.8%
2022-02-28 10 $177 $109 $151.7 $45.46 233.7%
2022-03-01 10 $182 $109 $152.2 $45.46 234.8%
2022-04-26 10 $182 $109 $152 $45.46 234.36%
2022-04-28 9 $182 $109 $151.1 $45.46 232.38%
2022-05-10 9 $182 $109 $151.35 $45.46 232.93%
2022-05-11 9 $170 $109 $148.2 $45.46 226%
2022-05-24 9 $165 $109 $145.8 $45.46 220.72%
2022-06-21 9 $165 $109 $147.15 $45.46 223.69%
2022-08-08 9 $165 $109 $146.833 $45.46 222.99%
2022-08-19 6 $165 $144 $152.333 $45.46 235.09%
2022-10-12 5 $165 $23 $127.9 $45.46 181.35%
2022-10-26 5 $165 $21 $101.1 $45.46 122.39%
2022-11-10 5 $148.5 $21 $55.375 $45.46 21.81%
2023-01-04 5 $27 $21 $24 $45.46 -47.21%
2023-03-24 6 $27 $21 $24 $45.46 -47.21%
2023-04-20 6 $31 $21 $24.75 $45.46 -45.56%
2023-04-24 6 $31 $21 $24.8 $45.46 -45.45%
2023-05-16 6 $31 $20 $24.2 $45.46 -46.77%
2023-05-17 6 $31 $21 $24.4 $45.46 -46.33%
2023-06-01 7 $31 $21 $25.2 $45.46 -44.57%
2023-06-06 7 $31 $21 $25 $45.46 -45.01%
2023-08-01 7 $31 $21 $26.4 $45.46 -41.93%
2023-08-16 7 $31 $23 $26.4 $45.46 -41.93%
2023-10-06 7 $31 $23 $26.8 $45.46 -41.05%
2023-10-08 7 $31 $25 $27.8 $45.46 -38.85%
2023-11-16 7 $36 $26 $31.8 $45.46 -30.05%
2023-11-20 8 $37 $31 $33.666 $45.46 -25.94%
2023-12-08 9 $58 $31 $37.142 $45.46 -18.3%
2023-12-22 9 $58 $31 $38.75 $45.46 -14.76%

The Trend in the Analyst Price Target


BHVN's average price target has moved up $13.95 over the prior 35 weeks.

BHVN reports an average of 37.09% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-24 6 27 21 24.000 18.73 28.14%
2023-03-23 6 27 21 24.000 13.40 79.1%
2023-04-25 6 31 20 24.200 13.41 80.46%
2023-06-16 7 31 21 26.400 23.65 11.63%
2023-12-08 9 58 31 37.142 33.06 12.35%

BHVN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 9 0 0 0 0 9

The Trend in the Broker Recommendations


BHVN's average broker recommendation rating improved by 0.36 over the prior 44 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how BIOHAVEN LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2304.52% of that group.
  • In terms of how BIOHAVEN LTD fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 3249.16% of that group.
  • BHVN has a lower variance in analysts' estimates than -1350.83% of Pharmaceutical Products stocks.
  • In the context of stocks in the mid market cap category, BIOHAVEN LTD's number of analysts covering the stock is higher than 2275.34% of them.

In the Pharmaceutical Products industry, GPCR, PASG, and BDTX are the three stocks most similar to BIOHAVEN LTD regarding the price target and analyst recommendation information presented here.

Is BHVN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!